Rocket Lab USA, Inc. (RKLB) Stock Analysis

68.0/100
Buy Not Halal Industrials
Price $61.53
Market Cap $38.89B
52-Week Change +35.98%

Is RKLB a good investment?

Rocket Lab USA, Inc. (RKLB) has a Plutrex AI rating of 68.0/100 as of November 09, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Forward EPS growth of 85.43% — 3x the A&D industry average of 28.46% — signals the most aggressive earnings normalization curve in the sector; combined with demonstrated 57.1% historical YoY EPS improvement (accelerating, not decelerating), the profitability inflection is progressing with quantitative evidence. Main concern: Technical momentum remains severely broken: stock has lost ~65% from May highs, is effectively flat from 14 days ago ($52.60→$53.07) with no base-building catalyst visible; news headline 'Rocket Lab Stock Has Lost About 70% From Its Record. Is It Finally a Buy?' captures the market's lingering uncertainty; momentum destruction of this magnitude typically requires weeks of base-building before safe entry.

Investment Summary

Rocket Lab (RKLB) at $53.07 is a pre-profitability hypergrowth aerospace company with 62% revenue growth, 85.4% forward EPS improvement, and a $2.3B cash fortress (D/E = 0.04x). Analyst consensus target of $100.00 implies 88.4% upside — a gap that has persisted and even widened as the stock fell ~65% from its May highs with no material fundamental deterioration. Gross margin of 34.1% vs. A&D industry average of 20.15% (+69% premium) validates unit economics. The company's $2.36B backlog confirms demand pipeline strength. Key headwinds: ongoing operating losses (-24.6% operating margin, -21.5% net margin), FCF burn of -$371M/year, unresolved Iridium acquisition regulatory risk, and broken technical momentum. The stock is +0.9% from 14 days ago ($52.60→$53.07) with the analyst target marginally declining from $100.88 to $100.00 — functionally no change. This is a conviction Buy with patience required for base-building.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
80/100
Growth Potential
78/100
Valuation
52/100
Profitability
25/100
Debt Management
82/100
Analyst Sentiment
62/100
Technical Momentum
36/100
Insider Confidence
45/100
News Sentiment
55/100

Fundamental Analysis

Revenue growth: 62.0% YoY — exceptional in absolute terms but below the 92.23% A&D peer group average, partly reflecting peer-group composition effects. Forward EPS growth: 85.43% (next year) vs. industry avg 28.46% — a +200% premium, the single most compelling forward metric. Gross margin: 34.11% vs. industry 20.15% — +69% premium confirms pricing power and unit economics quality. Operating margin: -24.57% vs. industry +11.73% — 36pp deficit reflecting heavy R&D and SG&A investment phase. Net margin: -21.51%. FCF: -$371M/year vs. $2.302B cash = 6.2 years runway at zero revenue growth. D/E: 0.04x vs. industry 0.53x — 92.4% less leveraged than peers. P/B: 9.09x — premium justified by hypergrowth trajectory. PE and PEG: N/A due to negative earnings. ROE: -7.92% vs. industry +21.56% — negative but modest in magnitude, expected for investment-phase company. The backlog of $2.36B provides revenue visibility. All fundamental metrics are UNCHANGED from prior report — the thesis is intact.

News Sentiment

Rocket Lab has had a rough year — but here's why some investors think the worst may be over. The space launch company has seen its stock crater nearly 70% from record highs, a painful decline that's left many investors wondering if they've missed the bottom or if more pain is coming. But here's the twist: analysts haven't given up. Their average price target remains near $100, almost double where the stock trades today around $53. So what's going on? According to recent coverage, the selloff appears to be driven more by sky-high expectations getting reset than by any fundamental collapse in the business. Rocket Lab still has a massive $2.36 billion backlog of orders — real contracts, real revenue coming in. Its workhorse Electron rocket continues flying reliably, keeping cash coming through the door while the company builds its bigger Neutron rocket. Headlines like 'RKLB Stock's Next Big Breakthrough Could Change Its Long-Term Growth Outlook' and 'Prediction: Rocket Lab Could Be Building the Space Company of the Future' suggest analysts and observers still believe in the long game. The company even made news for building a space robot — expanding its technology portfolio beyond launch. The key date to watch? November 9, flagged in headlines as potentially significant for investors. Bottom line: Rocket Lab is still losing money, but it's growing fast, sitting on over $2 billion in cash, and trading at a massive discount to what Wall Street thinks it's worth.

Risk Assessment

PRIMARY RISK: Iridium acquisition — if approved with $1.94B debt financing, D/E transforms from 0.04x to ~0.65x, FCF runway compresses sharply, and the balance sheet fortress thesis is compromised. This is a binary event requiring monitoring. SECONDARY RISK: Neutron development delays — headlines reference 'next big breakthrough' and execution credibility concerns; continued delays push back the medium-launch revenue opportunity that is central to the long-term bull case. TERTIARY RISK: Revenue growth deceleration — currently 62% but below peer avg of 92.23%; if it decelerates to 30-40%, the valuation premium (P/B 9.09x) would compress significantly. MITIGATION: 2.5% position size limits downside; $42.00 stop-loss provides ~17% downside buffer from $50.75 entry center; $2.3B cash eliminates solvency risk at current burn rate; 88.4% analyst target upside provides meaningful risk/reward buffer even with partial thesis realization.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is RKLB a halal stock?

No, Rocket Lab USA, Inc. (RKLB) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for RKLB?

Rocket Lab USA, Inc. (RKLB) has a Plutrex AI rating of 68.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is RKLB a good investment?

According to Plutrex AI, RKLB has a Buy rating (68.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in RKLB?

US stocks like RKLB can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in RKLB?

Plutrex AI identifies the main risks for RKLB by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about RKLB

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open RKLB in ElBarake